{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:16:51Z","timestamp":1788869811228,"version":"build-2803163510"},"reference-count":28,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2017,8,16]]},"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Magnesium sulphate has been demonstrated to be an effective neuroprotectant for babies delivered prematurely (under 37 weeks\u2019 gestational age). Antenatal administration reduces infant mortality and cerebral palsy (CP); however, uptake in the UK has been significantly lower than other countries. A quality improvement (QI) project (PReventing Cerebral palsy in Pre Term labour (PReCePT)) was carried out in the West of England, UK, to raise awareness of evidence and to improve the uptake of magnesium sulphate as neuroprotectant in preterm deliveries. Five National Health Service (NHS) Trusts and the West of England Academic Health Science Network participated in the QI project. The project was underpinned by a multifaceted QI approach that included: patient and clinical coproduction of resources; recruitment of clinical champions to support the local microsystems and create a stimulating\/supporting environment for change; Plan, Do, Study, Act cycles; training for over 600 NHS staff and awareness raising and strategic influencing of key leaders. A baseline audit and regular measurement of the number of eligible women receiving magnesium sulphate was undertaken at each hospital site, and the overall programme was evaluated using data from an international benchmarking organisation for neonatal care outcomes\u2014the Vermont Oxford Network. During the project 664 staff received magnesium sulphate training. The use of magnesium sulphate increased across the West of England from an average baseline of 21% over the 2 years preceding the project to 88% by the conclusion of the project. The project was also able to influence the development of a national data collection process for benchmarking the use of magnesium sulphate for neuroprotection in preterm deliveries in the U.K. PReCePT appears to have had a favourable effect on the uptake of magnesium sulphate across the West of England. The project has also provided learning about how to stimulate adoption and spread of evidence using a QI approach across a network.<\/jats:p>","DOI":"10.1136\/bmjoq-2017-000189","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T20:10:15Z","timestamp":1507925415000},"page":"e000189","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Preventing cerebral palsy in preterm labour: a multiorganisational quality improvement approach to the adoption and spread of magnesium sulphate for neuroprotection"],"prefix":"10.1136","volume":"6","author":[{"given":"Anna","family":"Burhouse","sequence":"first","affiliation":[{"name":"Quality Improvement, West of England Academic Health Science Network, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lea","sequence":"additional","affiliation":[{"name":"Maternity, United Bristol Hospital NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ray","sequence":"additional","affiliation":[{"name":"Quality Improvement, West of England Academic Health Science Network, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Bailey","sequence":"additional","affiliation":[{"name":"Maternity, Royal United Hospital Bath NHS Trust, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Davies","sequence":"additional","affiliation":[{"name":"Maternity, Great Western Hospitals NHS Foundation Trust, Swindon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Harding","sequence":"additional","affiliation":[{"name":"Maternity, United Bristol Hospital NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Howard","sequence":"additional","affiliation":[{"name":"Maternity, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Jordan","sequence":"additional","affiliation":[{"name":"Maternity, North Bristol NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noshin","family":"Menzies","sequence":"additional","affiliation":[{"name":"Quality Improvement, West of England Academic Health Science Network, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"White","sequence":"additional","affiliation":[{"name":"Quality Improvement, West of England Academic Health Science Network, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Phillips","sequence":"additional","affiliation":[{"name":"Quality Improvement, West of England Academic Health Science Network, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Luyt","sequence":"additional","affiliation":[{"name":"School of Clinical Science, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"2025083113255765000_6.2.e000189.1","doi-asserted-by":"crossref","unstructured":"Doyle LW , Crowther CA , Middleton P , et al . Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009:CD004661.doi:10.1002\/14651858.CD004661.pub3","DOI":"10.1002\/14651858.CD004661.pub3"},{"key":"2025083113255765000_6.2.e000189.2","unstructured":"Nightingale Internet Reporting System. Vermont oxford network database of very low birth weight infants born in 2012. Burlington, VT: Vermont Oxford Network. (accessed 4 Oct 2016)."},{"key":"2025083113255765000_6.2.e000189.3","unstructured":"Bliss. Neonatal Care in the UK: Facts and Statistics. (accessed Aug 2016)."},{"key":"2025083113255765000_6.2.e000189.4","doi-asserted-by":"publisher","DOI":"10.1080\/09638280500158422"},{"key":"2025083113255765000_6.2.e000189.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2008.03190.x"},{"key":"2025083113255765000_6.2.e000189.6","unstructured":"NHS Litigation Authority. Annual report and accounts. http:\/\/www.nhsla.com\/AboutUs\/Documents\/NHS_Litigation_Authority_Annual_Report_Accounts_2015-2016.pdf"},{"key":"2025083113255765000_6.2.e000189.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60136-1"},{"key":"2025083113255765000_6.2.e000189.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7976"},{"key":"2025083113255765000_6.2.e000189.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7961"},{"key":"2025083113255765000_6.2.e000189.10","doi-asserted-by":"crossref","unstructured":"Roberts D , Dalziel S . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006:CD004454.doi:10.1002\/14651858.CD004454.pub2","DOI":"10.1002\/14651858.CD004454.pub2"},{"key":"2025083113255765000_6.2.e000189.11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3443"},{"key":"2025083113255765000_6.2.e000189.12","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181ae98c2"},{"key":"2025083113255765000_6.2.e000189.13","unstructured":"Royal College of Obstetricians and Gynaecologists. Magnesium sulphate to prevent cerebral palsy following preterm birth: Scientific impact paper no. 29, 2011."},{"key":"2025083113255765000_6.2.e000189.14","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181d4ffa5"},{"key":"2025083113255765000_6.2.e000189.15","unstructured":"The University of Adelaide. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guidelines, 2010."},{"key":"2025083113255765000_6.2.e000189.16","unstructured":"Office of National Statistics. Characteristics of birth 1, 2012."},{"key":"2025083113255765000_6.2.e000189.17","unstructured":"Nightingale Internet Reporting System. Vermont oxford Nntwork database of very low birth weight infants born in 2013. Burlington, VT: Vermont Oxford Network, 2013. (accessed on 4 Oct 2016)."},{"key":"2025083113255765000_6.2.e000189.18","unstructured":"Bliss for babies born premature or sick. http:\/\/www.bliss.org.uk"},{"key":"2025083113255765000_6.2.e000189.19","unstructured":"Langley G , Moen R , Nolan KM , et al ; The improvement guide: a practical approach to enhancing organizational performance. 2nd edition. San Francisco, California, USA: Jossey-Bass Publishers, 2009."},{"key":"2025083113255765000_6.2.e000189.20","unstructured":"Bate SP , Robert G . Bringing user experience to healthcare improvement: the concepts methods and practices of experience-based design: Oxford Radcliffe Publishing, 2007."},{"key":"2025083113255765000_6.2.e000189.21","unstructured":"Godfrey M , Nelson E , Batalden P , et al . Clinical microsystem action guide: improving health care by improving your microsystem: Dartmouth College, 2004."},{"key":"2025083113255765000_6.2.e000189.22","unstructured":"L\u00f6ffler E . Why co-production is an important topic for local government. 2013 http:\/\/www.govint.org\/fileadmin\/user_upload\/publications\/coproduction_why_it_is_important.pdf"},{"key":"2025083113255765000_6.2.e000189.23","unstructured":"Preterm labour and birth: nice.org.uk\/guidance\/ng25: NICE guideline, 2015."},{"key":"2025083113255765000_6.2.e000189.24","unstructured":"The Royal College of Paediatrics and Child Health. NNAP 2016 dataset audit measures. audit measures.v.1.pdf2016 http:\/\/www.rcpch.ac.uk\/system\/files\/protected\/page\/2016"},{"key":"2025083113255765000_6.2.e000189.25","unstructured":"Info Queue. Lean project management using \"Oobeya\". https:\/\/www.infoq.com\/articles\/lean-project-management-oobeya"},{"key":"2025083113255765000_6.2.e000189.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-7"},{"key":"2025083113255765000_6.2.e000189.27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/ajo.12334","article-title":"Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women\u2019s and Children\u2019s Hospital, Adelaide 2010-2013","volume":"55","author":"Siwicki","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025083113255765000_6.2.e000189.28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12884-015-0618-9","article-title":"Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework","volume":"15","author":"Bain","year":"2015","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2017-000189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T20:26:05Z","timestamp":1756671965000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2017-000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,10,12]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/bmjoq-2017-000189"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2017-000189","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}